Double maintains 1 strategies that include NVS - Novartis AG
Current Value
$118.181 Year Return
Current Value
$118.181 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -15.09% | $20.27M | +118.75% | 0.00% |
DFDV | -14.02% | $363.80M | +2,684.66% | 0.00% |
TLN | -13.12% | $12.20B | +99.87% | 0.00% |
STRL | -12.69% | $7.25B | +84.15% | 0.00% |
MYRG | -11.36% | $2.87B | +25.25% | 0.00% |
ALAB | -10.59% | $15.23B | +60.57% | 0.00% |
RDDT | -10.06% | $26.72B | +105.56% | 0.00% |
LITE | -9.45% | $6.81B | +66.09% | 0.00% |
CEG | -9.32% | $99.66B | +55.21% | 0.46% |
CCRN | -9.15% | $395.37M | -20.61% | 0.00% |
LITB | -8.97% | $25.19M | -67.38% | 0.00% |
ANF | -8.71% | $4.25B | -47.56% | 0.00% |
FVRR | -8.46% | $942.62M | +3.92% | 0.00% |
PWR | -8.22% | $57.28B | +49.03% | 0.10% |
VRT | -7.85% | $48.54B | +41.96% | 0.11% |
PRIM | -7.68% | $4.65B | +62.52% | 0.35% |
FIX | -7.56% | $19.01B | +63.32% | 0.28% |
GEV | -7.39% | $152.74B | +206.23% | 0.04% |
COHR | -7.25% | $14.93B | +19.37% | 0.00% |
MRVL | -7.09% | $62.43B | -4.22% | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GSK | 65.56% | $76.43B | -2.78% | 4.23% |
AZN | 62.82% | $218.09B | -10.52% | 2.20% |
JNJ | 55.76% | $373.35B | +2.75% | 3.07% |
PFE | 54.17% | $139.92B | -16.58% | 6.83% |
UL | 53.89% | $147.86B | +5.09% | 3.22% |
HLN | 52.28% | $43.71B | +11.20% | 1.82% |
NGG | 52.17% | $69.61B | +16.41% | 4.35% |
ABT | 51.69% | $228.77B | +28.01% | 2.17% |
KO | 50.98% | $298.54B | +7.92% | 2.87% |
SBAC | 48.71% | $24.72B | +7.96% | 1.81% |
D | 48.65% | $48.23B | +10.26% | 4.69% |
AMGN | 48.55% | $157.28B | -12.20% | 3.15% |
AEP | 48.43% | $55.77B | +13.66% | 3.51% |
SO | 48.21% | $101.63B | +13.99% | 3.12% |
SNY | 47.88% | $117.24B | -3.86% | 4.52% |
ES | 47.63% | $23.78B | +8.37% | 4.52% |
POR | 47.56% | $4.42B | -12.35% | 4.99% |
TAK | 47.20% | $46.42B | +10.90% | 4.51% |
DTE | 46.88% | $27.67B | +16.26% | 3.21% |
ATO | 46.83% | $24.48B | +25.96% | 2.21% |
Yahoo
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
Yahoo
Strong sales of Entresto, Kisqali, Kesimpta, Leqvio and Scemblix have likely benefited NVS' Q2 performance and offset the impact of generics.
Yahoo
The big US banks bested Q1 earnings expectations, and many observers expect big boosts to their Q2 trading desk revenues.
Yahoo
BAYRY wins FDA nod to expand Kerendia's label, making it the only approved non-steroidal MR antagonist for two major conditions.
Yahoo
Get a deeper insight into the potential performance of Novartis (NVS) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Yahoo
Novartis' (VTX:NOVN) stock is up by 6.7% over the past three months. As most would know, long-term fundamentals have a...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
JOBY | -0.01% | $11.05B | +87.00% | 0.00% |
CABO | -0.04% | $673.42M | -67.06% | 7.32% |
CVLT | 0.05% | $7.42B | +33.60% | 0.00% |
ONTO | -0.08% | $4.88B | -58.12% | 0.00% |
TPG | -0.09% | $7.48B | +13.53% | 3.17% |
JILL | -0.12% | $223.13M | -62.31% | 2.01% |
CPRI | 0.13% | $2.20B | -47.20% | 0.00% |
AGX | -0.13% | $3.03B | +179.22% | 0.64% |
DAVE | 0.14% | $2.70B | +385.82% | 0.00% |
FLXS | 0.16% | $197.91M | +1.16% | 1.89% |
AVPT | -0.18% | $3.76B | +73.48% | 0.00% |
AAON | 0.18% | $6.04B | -21.53% | 0.48% |
SEER | -0.20% | $123.58M | +8.81% | 0.00% |
PCT | 0.25% | $2.71B | +150.92% | 0.00% |
META | -0.26% | $1.79T | +45.04% | 0.29% |
KRNT | -0.27% | $895.67M | +21.90% | 0.00% |
MOGO | 0.27% | $46.74M | +17.33% | 0.00% |
ULH | 0.28% | $679.40M | -42.60% | 1.63% |
FLUT | -0.31% | $51.84B | +41.10% | 0.00% |
ARLO | 0.32% | $1.67B | -4.83% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SATO | -0.30% | $11.77M | 0.6% |
BITQ | 0.32% | $255.42M | 0.85% |
DAPP | 0.40% | $243.82M | 0.51% |
DBC | 0.40% | $1.27B | 0.87% |
XHLF | -0.45% | $1.75B | 0.03% |
PDBC | 0.56% | $4.59B | 0.59% |
CRPT | 0.64% | $153.04M | 0.85% |
BILZ | 0.65% | $838.22M | 0.14% |
GBIL | -0.66% | $6.37B | 0.12% |
CONY | -0.74% | $1.44B | 1.22% |
FTSD | -0.80% | $233.17M | 0.25% |
TBLL | -0.95% | $2.11B | 0.08% |
UNG | -1.02% | $422.40M | 1.06% |
BKCH | 1.02% | $195.15M | 0.5% |
YBTC | -1.16% | $240.94M | 0.96% |
MAGS | -1.48% | $2.36B | 0.29% |
SHYM | 1.74% | $355.36M | 0.35% |
FBY | -1.77% | $180.86M | 1.06% |
COMT | 1.98% | $619.71M | 0.48% |
ARKW | 2.14% | $2.15B | 0.82% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -27.93% | $130.22M | 0.5% |
UUP | -27.56% | $187.70M | 0.77% |
VIXY | -21.02% | $198.83M | 0.85% |
TAIL | -19.61% | $94.79M | 0.59% |
VIXM | -15.37% | $23.12M | 0.85% |
CLIP | -11.32% | $1.51B | 0.07% |
TPMN | -10.24% | $31.00M | 0.65% |
TESL | -8.70% | $32.83M | 1.2% |
CETH | -7.41% | $32.52M | 0% |
FETH | -7.37% | $1.66B | 0.25% |
EETH | -7.32% | $74.37M | 0.95% |
ETHV | -7.31% | $154.85M | 0% |
QETH | -7.21% | $27.41M | 0.25% |
ETHA | -7.20% | $6.14B | 0.25% |
EZET | -7.18% | $47.83M | 0% |
KCCA | -7.17% | $109.69M | 0.87% |
ETH | -7.15% | $1.40B | 0% |
ETHW | -7.00% | $347.89M | 0% |
BOXX | -6.18% | $6.96B | 0.19% |
BTF | -6.12% | $36.51M | 1.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 71.74% | $537.40M | 0.36% |
EWL | 70.14% | $1.33B | 0.5% |
IXJ | 67.15% | $3.76B | 0.41% |
EFAV | 62.73% | $5.44B | 0.2% |
HDEF | 61.04% | $2.05B | 0.09% |
ACWV | 60.37% | $3.26B | 0.2% |
KXI | 60.19% | $847.76M | 0.41% |
DWX | 59.53% | $475.15M | 0.45% |
GCOW | 59.10% | $2.36B | 0.6% |
XLV | 58.90% | $33.63B | 0.09% |
SCHY | 58.64% | $1.19B | 0.08% |
IYH | 58.01% | $2.73B | 0.39% |
FICS | 57.66% | $222.95M | 0.7% |
NFRA | 57.47% | $2.74B | 0.47% |
VHT | 57.23% | $15.33B | 0.09% |
FHLC | 57.10% | $2.43B | 0.084% |
EWU | 56.51% | $3.03B | 0.5% |
IHE | 56.43% | $557.84M | 0.39% |
IYK | 56.29% | $1.42B | 0.4% |
HDV | 56.02% | $11.22B | 0.08% |